|
1
|
Ferlay J, Parkin DM and Steliarova-Foucher
E: Estimates of cancer incidence and mortality in Europe in 2008.
Eur J Cancer. 46:765–81. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar
|
|
3
|
Therasse P, Arbuck SG, Eisenhauer EA,
Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van GM, van Oosterom
AT, Christian MC and Gwyther SG: New guidelines to evaluate the
response to treatment in solid tumors. European Organization for
Research and Treatment of Cancer, National Cancer Institute of the
United States, National Cancer Institute of Canada. J Natl Cancer
Inst. 92:205–216. 2000. View Article : Google Scholar
|
|
4
|
Kidd EA, Siegel BA, Dehdashti F and
Grigsby PW: The standardized uptake value for F-18
fluorodeoxyglucose is a sensitive predictive biomarker for cervical
cancer treatment response and survival. Cancer. 110:1738–1744.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Larson SM and Schwartz LH: 18F-FDG PET as
a candidate for ‘qualified biomarker’: functional assessment of
treatment response in oncology. J Nucl Med. 47:901–903. 2006.
|
|
6
|
Weber WA: Positron emission tomography as
an imaging biomarker. J Clin Oncol. 24:3282–3292. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boellaard R: Standards for PET image
acquisition and quantitative data analysis. J Nucl Med. 50(Suppl
1): S11–S20. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cheebsumon P, Velasquez LM, Hoekstra CJ,
Hayes W, Kloet RW, Hoetjes NJ, Smit EF, Hoekstra OS, Lammertsma AA
and Boellaard R: Measuring response to therapy using FDG PET:
semi-quantitative and full kinetic analysis. Eur J Nucl Med Mol
Imaging. January 6–2011.(Epub ahead of print).
|
|
9
|
Shankar LK, Hoffman JM, Bacharach S,
Graham MM, Karp J, Lammertsma AA, Larson S, Mankoff DA, Siegel BA,
Van den Abbeele A, Yap J and Sullivan D: Consensus recommendations
for the use of 18F-FDG PET as an indicator of therapeutic response
in patients in National Cancer Institute Trials. J Nucl Med.
47:1059–1066. 2006.PubMed/NCBI
|
|
10
|
Weber WA: Use of PET for monitoring cancer
therapy and for predicting outcome. J Nucl Med. 46:983–995.
2005.PubMed/NCBI
|
|
11
|
Freedman NM, Sundaram SK, Kurdziel K,
Carrasquillo JA, Whatley M, Carson JM, Sellers D, Libutti SK, Yang
JC and Bacharach SL: Comparison of SUV and Patlak slope for
monitoring of cancer therapy using serial PET scans. Eur J Nucl Med
Mol Imaging. 30:46–53. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang SC: Anatomy of SUV. Standardized
uptake value. Nucl Med Biol. 27:643–646. 2000.PubMed/NCBI
|
|
13
|
Boellaard R, O’Doherty MJ, Weber WA,
Mottaghy FM, Lonsdale MN, Stroobants SG, Oyen WJ, Kotzerke J,
Hoekstra OS, Pruim J, et al: FDG PET and PET/CT: EANM procedure
guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol
Imaging. 37:181–200. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Young H, Baum R, Cremerius U, Herholz K,
Hoekstra O, Lammertsma AA, Pruim J and Price P: Measurement of
clinical and subclinical tumour response using
[18F]-fluorodeoxyglucose and positron emission tomography: review
and 1999 EORTC recommendations. European Organization for Research
and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer.
35:1773–1782. 1999.
|
|
15
|
Teräs M, Tolvanen T, Johansson JJ,
Williams JJ and Knuuti J: Performance of the new generation of
whole-body PET/CT scanners: Discovery STE and Discovery VCT. Eur J
Nucl Med Mol Imaging. 34:1683–1692. 2007.PubMed/NCBI
|
|
16
|
Benz MR, Evilevitch V, Allen-Auerbach MS,
Eilber FC, Phelps ME, Czernin J and Weber WA: Treatment monitoring
by 18F-FDG PET/CT in patients with sarcomas: interobserver
variability of quantitative parameters in treatment-induced changes
in histopathologically responding and nonresponding tumors. J Nucl
Med. 49:1038–1046. 2008. View Article : Google Scholar
|
|
17
|
Marom EM, Munden RF, Truong MT, Gladish
GW, Podoloff DA, Mawlawi O, Broemeling LD, Bruzzi JF and Macapinlac
HA: Interobserver and intraobserver variability of standardized
uptake value measurements in non-small-cell lung cancer. J Thorac
Imaging. 21:205–212. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Altman DG: Statistics and ethics in
medical research: III How large a sample? Br Med J. 281:1336–1338.
1980. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
D’Agostino RB and Pearson ES: Tests for
departure from normality. Empirical results for the distributions
of b2 and √b1. Biometrika.
60:613–622. 1973.
|
|
20
|
D’Agostino RB and Stephens MA:
Goodness-of-Fit Techniques. Marcel Dekker; New York: 1986
|
